• Syneron raises $150m for macrocyclics, and other financings
  • Sidewinder Therapeutics raises $137M in Series B round
Sidewinder Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    215 followers

  • Elon Musk

    Elon Musk

    81 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    59 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    217 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeSidewinder Therapeutics
Sidewinder Therapeutics logo

Sidewinder Therapeutics

0 followers

About Sidewinder Therapeutics

Sidewinder Therapeutics is a biopharmaceutical company focused on developing precision biologics, aiming to deliver large-molecule therapies for cancer and rare diseases. The company emphasizes next-generation precision therapeutics and innovative medicines driven by a team of experienced scientists and drug developers. It highlights leadership in drug discovery and development with a focus on targeted molecular drivers of disease. The organization appears to be based in the United States, with an emphasis on advanced oncology and rare-disease programs.

Recent News

Syneron Raises $150m for Macrocyclics, and Other Financings

Recent Deals

Sidewinder Therapeutics Raises $137M in Series B Round

April 8, 2026

Key Team Members

Eric Murphy, Ph.D.

Chief Executive Officer, Co-Founder, & Director

Rob McRae

President & Chief Operating Officer

Michael Mueller

General Counsel

Key Facts

HQ Location

San Diego, United States

Founded

2023

Employees

11 - 50

Status

Private

Website

https://sidewinderbio.com